Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PET Imaging of Tumors in Pancreas, Bile Ducts, Stomach and Ovaries by a Novel Tracer, 68Ga-FAPI-46 = Fibroblast Activation Protein Inhibitor

NCT05172310 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT05172310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05172310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PET Imaging of Tumors in Pancreas, Bile Ducts, Stomach and Ovaries by a Novel Tracer, 68Ga-FAPI-46 = Fibroblast Activation Protein Inhibitor
Lead sponsor
Karolinska University Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
June 2, 2021
Completion date
March 31, 2029
Enrollment
410 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bile duct neoplasms, epithelial ovarian cancer, pancreatic neoplasms, stomach neoplasms